Effects of long-term estrogen replacement treatment on the blood pressure and expression of IR and IRS-1 in myocardium

Journal of Central South University (Medical Sciences)

Volumn 30, Issue 1, 2005, Pages

  Liu, Mei Lian ^a   Xu, Xia ^a   Xie, Ping ^a   Lu, Jin ^a   Chen, Shu Hua ^a   Zeng, Wei Min ^a   Song, Hui Ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Blood pressure; Insulin receptor; Insulin receptor substrate 1; Insulin sensitivity; Long term estrogen replacement treatment

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1;

ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEART MUSCLE; LONG TERM CARE; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; TAIL ARTERY;

ANIMALS; BLOOD PRESSURE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; MYOCARDIUM; OVARIECTOMY; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; TIME FACTORS;

EID: 33746642576     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Shen BJ, Todaro JF, Niaura R, et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome x[J]. Am J Epidemiol, 2003, 157(8): 701-11.
2. Spencer CP, Godsland IF, Cooper AJ, et al. Effects of oral and transdermal 17 beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women[J]. Metabolism, 2000, 49(6): 742-750.
3. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initative randomized controlled trial[J]. J Am Med Assoc, 2002, 288(3): 32l-333.
4. Liu ML, Xu X, Song HP, et al. Influence of ovariectomy and 17β-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function[J]. Inter J Cardiol, 2004, 75(3): 485-493.
5. Rappelli A. Hypertension and obesity after the menopause[J]. J Hypertens, 2002, 20(suppl 2): S26-S28.
6. Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats[J]. Acta Physiol Scand, 1993, 149(1): 91-97.
7. Preston RA, Alonso A, Panzitta D, et al. Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril[J]. Am J Hypertens, 2002, 15(9): 816-822.
8. Reynolds LP, Arnold DR, Kraft KC ,et al. Co-immunolocalization of endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) in endometrial vasculature of estradiol-treated ovariectomized ewes[J]. Bio Reprod, 2000, 62(suppl): 342.
9. Beato M. Gene regulation by steroid hormone[J]. Cell, 1989, 56 (3): 335-344.
10. Morelli C, Garofalo C, Bartucci M, et al. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells[J]. Oncogene, 2003, 22(26): 4007-4016.
11. Xie P, Liu ML, Gu YP, et al. Oestrogen improve glucose metabolism and insulin signal transduction in HepG2 cells[J]. Clin Exp Pharm Physiol, 2003, 30(9): 643-648.
12. Scholz A, Truss M, Beato M, et al. Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium[J]. J Biol Chem, 1998, 273(6): 4360-4366.
13. Molloy CA, May FEB, Westly BR. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line[J]. J Bio Chem, 2000, 275(17): 12565-12571.